This seems to me more than just coincidence considering the profile of product pipelines and therapeutic areas both companies bet on.
I was watching both for some time and placed a position to $ABBV before earnings @ major support level, which was broken and then turned.
Major support @ 468 (50% monthly Fib level)
Potential upside to 700 with test of ATH 664.
Very good R/R of 1:7.
Good fundamentals on top of above made $REGN a definitive buy for me as I was waiting a good price to enter.
Discussion purpose only, not an advice.
I was watching both for some time and placed a position to $ABBV before earnings @ major support level, which was broken and then turned.
Major support @ 468 (50% monthly Fib level)
Potential upside to 700 with test of ATH 664.
Very good R/R of 1:7.
Good fundamentals on top of above made $REGN a definitive buy for me as I was waiting a good price to enter.
Discussion purpose only, not an advice.
